Psoriatic Arthritis Market Info™ - Updated for 2012

Published by: Drug Market Info

Published: May. 1, 2012 - 84 Pages


Table of Contents

1. Patients: Understanding Psoriatic Arthritis (19 slides)
Description, Epidemiology, Disease Classification, Important PsA Clinical Features, Diagnosis, PsA Key Facts, Featured PsA Patient, Patient Insights
2. Perspectives: Psoriatic Arthritis Management (28 slides)
PsA Treatment Goals, PsA Therapy Overview, Treatment Assessment Tools, Mild PsA: Therapeutic Profiles, Benefits/Risks, Moderate/Severe PsA: DMARD Profiles, Benefits/Risks, Moderate/Severe PsA: Biologic Profiles, Benefits/Risks, Physicians Treating PsA, PsA Treatment Dynamics, Patient Insights on PsA Treatment, PsA Therapy: Key Issues
3. Potential: The Psoriatic Arthritis Market (19 slides)
PsA Market Definition, PsA Sales by Treatment Type, 5-Year Sales Trends by Treatment Type, Sales Versus Prescription Share by Treatment Type, 5-Year Prescription Trends, Leading Product Sales and Companies, Most Frequently Used PsA Products, PsA Therapy Costs, Price to Patients, PsA Pipeline: Overview, Targets, Late Stage, PsA Patient Insights
Psoriatic Arthritis Summary
Why the PsA Market is Attractive, Six Most Important Facts About PsA, What Patients Want, National Psoriasis Foundation (NPF), Clinician Reviewer
Appendix:
Acknowledgements, Market Value Calculation, Helpful Resources, About the Authors, Other Services, Bibliography

Abstract

Psoriatic Arthritis (PsA) is a form of arthritis that is often associated with psoriasis of the skin. Up to 30% of people with psoriasis also develop psoriatic arthritis, which causes pain, stiffness and swelling in and around the joints. Genetic predisposition, the immune system and environmental factors are all believed to play a role in the onset of Psoriatic Arthritis. Without treatment, this chronic, debilitating disease can be life-altering.

With the increased use of biologics, such as Enbrel® (Amgen/Pfizer), the Psoriatic Arthritis market has experienced strong growth over the past few years. In addition, the cost of these therapies has driven the market to the $1 billion+ level. Psoriatic Arthritis Market Info™ from Drug Market Info captures explicit data on this disorder, which is often hard to obtain. In many cases, PsA market information tends to be “lumped” or buried within data for rheumatoid arthritis or psoriasis. For this reason, Psoriatic Arthritis Market Info specifically focuses only on this condition.

It’s as easy as one, two, three with Psoriatic Arthritis Market Info. Insights on patients, doctors, treatment and market value are presented in an easy-to-follow format with reliable, referenced data.

Section One: Patients - Understanding Psoriatic Arthritis: Focuses on patients and how they feel about their disease. Includes basic disease information, as well as epidemiology.

Section Two: Perspectives - Psoriatic Arthritis Management: A review of therapies, advantages and disadvantages, listing of major products and companies. Includes patients’ perspectives, experiences and insights on various therapies.

Section Three: Potential - Psoriatic Arthritis Market: Overall sales and prescription volume, growth rates and key products and companies provided. Includes pipeline products and market attractiveness assessment.

Summary: The major take-aways from the presentation, including “What Makes the Psoriatic Arthritis Market Attractive,” “Six Most Important Facts About the PsA Market,” “Patient Insights” and a statement from the National Psoriasis Foundation (NPF).

Get full details about this report >>
 
Learn more about this product


Price and delivery options
Search Inside Report

US: 800.298.5699

Int'l: +1.240.747.3093

 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 400,000 market research reports, company profiles and country profiles from over 720 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.